Search

for
Search:

Glossary Infliximab

blocks TNF-alpha to reduce inflammation in autoimmune diseases

Infliximab, also known by the brand name Remicade, is a medication that works by blocking a protein called tumor necrosis factor-alpha (TNF-alpha). This protein is involved in inflammatory processes in the body. By inhibiting TNF-alpha, infliximab helps reduce inflammation and is used to treat autoimmune conditions such as rheumatoid arthritis, Crohn's disease, and psoriasis.

Related Terms

Research

5 / 567 results

Severe Infliximab-Induced Alopecia and Scalp Psoriasis in a Woman with Crohn’s Disease: Dramatic Improvement After Drug Discontinuation and Treatment with Adjuvant Systemic and Topical Therapies

research Severe Infliximab-Induced Alopecia and Scalp Psoriasis in a Woman with Crohn’s Disease: Dramatic Improvement after Drug Discontinuation and Treatment with Adjuvant Systemic and Topical Therapies

19 citations , November 2016 in “Dermatology and therapy”

This study describes a case where stopping infliximab and using oral minocycline with topical treatments effectively resolved alopecia and scalp psoriasis in a woman with Crohn's disease.

research Hyperammonemia with Valproic Acid: Colonic Ischemia Associated with “Triptan” Use Visual Side Effects with Pegylated Interferon: Alopecia Areata with Infliximab: Adverse Effects Seen with Medications Used for Irritable Bowel Syndrome

2 citations , November 2004 in “Hospital pharmacy”

This article reviews adverse drug reactions, emphasizes methods of prevention, and encourages reporting to the FDA's medWatch program, but presents no new study findings.

View more "infliximab" in research →